References
Waldek S, Feriozzi S (2014) Fabry nephropathy: a review—how can we optimize the management of nephropathy? BMC Nephrol 15:1471–2369
Chen HC, Tsai JH, Lai YH, Guh JY (1990) Renal changes in heterozygous Fabry’s disease—a family study. Am J Kidney Dis 15:180–183
Terryn W, Cochat P, Froissart R, Ortiz A, Pirson Y, Poppe B, Serra A, Van Biesen W, Vanholder R, Wanner C (2013) Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European renal best practice. Nephrol Dial Transplant 28:505–517
Linthorst GE, Vedder AC, Aerts JM, Hollak CE (2005) Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta 353:201–203
Gal A, Hughes DA, Winchester B (2011) Toward a consensus in the laboratory diagnostics of Fabry disease—recommendations of a European expert group. J Inherit Metab Dis 34:509–514
Paschke E, Fauler G, Winkler H, Schlagenhauf A, Plecko B, Erwa W, Breunig F, Urban W, Vujkovac B, Sunder-Plassmann G, Kotanko P (2011) Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study. Am J Kidney Dis 57:673–681
Selvarajah M, Nicholls K, Hewitson TD, Becker GJ (2011) Targeted urine microscopy in Anderson–Fabry disease: a cheap, sensitive and specific diagnostic technique. Nephrol Dial Transplant 26:3195–3202
Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30
Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. Eur J Clin Investig 34:236–242
Ellaway C (2016) Paediatric Fabry disease. Transl Pediatr 5:37–42
Schiffmann R, Fuller M, Clarke LA, Aerts JM (2016) Is it Fabry disease? Genet Med 18:1181–1185
Hopkin RJ, Jefferies JL, Laney DA, Lawson VH, Mauer M, Taylor MR, Wilcox WR, Fabry Pediatric Expert Panel (2016) The management and treatment of children with Fabry disease: a United States-based perspective. Mol Genet Metab 117:104–113
Oder D, Nordbeck P, Wanner C (2016) Long term treatment with enzyme replacement therapy in patients with Fabry disease. Nephron 134:30–36
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
This refers to the article that can be found at https://doi.org/10.1007/s00467-017-3822-1.
Rights and permissions
About this article
Cite this article
Kaya Aksoy, G., Çomak, E., Akkaya, B. et al. Proteinuria in a male adolescent with hearing loss: Answers. Pediatr Nephrol 33, 1161–1163 (2018). https://doi.org/10.1007/s00467-017-3825-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-017-3825-y